Louisiana State Employees Retirement System’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.27M Buy
11,500
+100
+0.9% +$29.9K 0.06% 238
2026
Q1
$2.94M Sell
11,400
-400
-3% -$106K 0.05% 345
2025
Q4
$2.91M Hold
11,800
0.05% 341
2025
Q3
$2.08M Sell
11,800
-100
-0.8% -$15K 0.04% 520
2025
Q2
$1.64M Hold
11,900
0.03% 637
2025
Q1
$2.15M Sell
11,900
-300
-2% -$50.5K 0.04% 442
2024
Q4
$1.91M Hold
12,200
0.04% 541
2024
Q3
$2.22M Sell
12,200
-300
-2% -$57.8K 0.04% 457
2024
Q2
$2.3M Buy
+12,500
New +$2.1M 0.04% 394

Other funds holding KRYS

Louisiana State Employees Retirement System's KRYS Position: Q2 2026 in Review

Louisiana State Employees Retirement System increased its Krystal Biotech (KRYS) stake by 0.88% in Q2 2026, buying an estimated $29.9K and bringing the position to 11,500 shares worth $4.27M. The position accounts for 0.06% of the portfolio, ranked #238.

Louisiana State Employees Retirement System first reported a position in KRYS in Q2 2024 and has held it in 9 quarters since. 102 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Louisiana State Employees Retirement System held 11,500 shares of Krystal Biotech worth $4.27M as of Q2 2026.
  • Louisiana State Employees Retirement System bought 100 Krystal Biotech shares in Q2 2026, an estimated $29.9K.
  • Krystal Biotech made up 0.06% of Louisiana State Employees Retirement System's portfolio in Q2 2026, its #238 holding.
  • Louisiana State Employees Retirement System first reported a position in Krystal Biotech in Q2 2024 and has held it in 9 quarters since.
  • 102 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Louisiana State Employees Retirement System's 13F filing for Q2 2026, filed 20 Jul 2026.